Advertisement
Advertisement
U.S. markets close in 2 hours 11 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Alterity Therapeutics Limited (ATHE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6602+0.0053 (+0.81%)
As of 01:31PM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/23/2022
Current
Market Cap (intraday)
25.13M
Enterprise Value
-596.70k
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
737.73
Price/Book (mrq)
0.85
Enterprise Value/Revenue
114.68
Enterprise Value/EBITDA
0.04

Trading Information

Stock Price History

Beta (5Y Monthly) 0.95
52-Week Change 3-50.76%
S&P500 52-Week Change 3-9.13%
52 Week High 32.7500
52 Week Low 30.5800
50-Day Moving Average 30.6934
200-Day Moving Average 30.9117

Share Statistics

Avg Vol (3 month) 387.02k
Avg Vol (10 day) 3105.07k
Shares Outstanding 540.11M
Implied Shares Outstanding 6N/A
Float 833.39M
% Held by Insiders 10.00%
% Held by Institutions 11.95%
Shares Short (May 30, 2022) 4248.01k
Short Ratio (May 30, 2022) 43.99
Short % of Float (May 30, 2022) 4N/A
Short % of Shares Outstanding (May 30, 2022) 40.62%
Shares Short (prior month Apr 28, 2022) 4385.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Mar 23, 2016

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 29, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin -276.84%
Operating Margin (ttm)-336.93%

Management Effectiveness

Return on Assets (ttm)-24.63%
Return on Equity (ttm)-35.32%

Income Statement

Revenue (ttm)4.82M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)25.30%
Gross Profit (ttm)3.98M
EBITDA -16.21M
Net Income Avi to Common (ttm)-13.33M
Diluted EPS (ttm)-0.2400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37M
Total Cash Per Share (mrq)0.92
Total Debt (mrq)41.89k
Total Debt/Equity (mrq)0.10
Current Ratio (mrq)11.92
Book Value Per Share (mrq)1.02

Cash Flow Statement

Operating Cash Flow (ttm)-18.67M
Levered Free Cash Flow (ttm)-13.65M
Advertisement
Advertisement